Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · IEX Real-Time Price · USD
1.000
-0.010 (-0.99%)
At close: Jul 19, 2024, 4:00 PM
1.010
+0.010 (1.00%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of $188.82 million as of July 22, 2024. Its market cap has decreased by -18.40% in one year.
Market Cap
188.82M
Enterprise Value
148.46M
1-Year Change
-18.40%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $188.82M, an increase of 28.10%. That is a compound annual growth rate of 0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 188.80M | -1.00% |
| Dec 29, 2023 | 190.70M | -4.12% |
| Dec 30, 2022 | 198.90M | -51.84% |
| Dec 31, 2021 | 413.00M | 56.44% |
| Dec 31, 2020 | 264.00M | 98.05% |
| Dec 31, 2019 | 133.30M | 15.01% |
| Dec 31, 2018 | 115.90M | -57.51% |
| Dec 29, 2017 | 272.80M | -26.90% |
| Dec 30, 2016 | 373.20M | -4.09% |
| Dec 31, 2015 | 389.10M | 25.52% |
| Dec 31, 2014 | 310.00M | 28.15% |
| Dec 31, 2013 | 241.90M | 51.38% |
| Dec 31, 2012 | 159.80M | -45.26% |
| Dec 30, 2011 | 291.90M | -26.38% |
| Dec 31, 2010 | 396.50M | 181.41% |
| Dec 31, 2009 | 140.90M | 234.68% |
| Dec 31, 2008 | 42.10M | 347.87% |
| Dec 31, 2007 | 9.40M | 54.10% |
| Dec 29, 2006 | 6.10M | 10.91% |
| Dec 30, 2005 | 5.50M | -79.55% |
| Dec 31, 2004 | 26.90M | 43.09% |
| Dec 31, 2003 | 18.80M | -10.05% |
| Dec 31, 2002 | 20.90M | -60.79% |
| Dec 31, 2001 | 53.30M | -37.37% |
| Dec 29, 2000 | 85.10M | -11.72% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ClearPoint Neuro | 193.86M |
| Generation Bio Co. | 191.60M |
| Greenwich LifeSciences | 191.01M |
| G1 Therapeutics | 189.78M |
| EDAP TMS | 189.23M |
| Fractyl Health | 188.71M |
| Coherus BioSciences | 188.15M |
| Inhibrx | 186.45M |